PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
09-Feb-2024 Global HDL Cholesterol Kits Market indicates it will surpass US$ 786.2 Million by 2029, with a steady CAGR of 4.8%, according to FMI’s analysis MARKITWIRED
09-Feb-2024 Global Viscosupplementation Market is estimated to attain US$ 3,777.4 million by 2034 to witness a robust CAGR of 5.7% | FMI MARKITWIRED
09-Feb-2024 Global Vision Screeners Market to attain a worth of US$ 815.2 Million by 2029, registering a CAGR of 5.9% | FMI MARKITWIRED
09-Feb-2024 Baron & Budd: Court Approves Massive $1.1 Billion Settlement With DuPont to Resolve “Forever Chemicals” Contamination Suits Businesswire
09-Feb-2024 Takeda Intends to Rapidly Initiate the First Global Phase 3 Trials of TAK-861, an Oral Orexin Agonist, in Narcolepsy Type 1 in First Half of Fiscal Year 2024 Businesswire
09-Feb-2024 Sensient Technologies Corporation Reports Results for the Quarter Ended December 31, 2023 Businesswire
09-Feb-2024 ACI: NYC Bill to Restrict Safe Detergent Chemistry is Unnecessary, Would Disrupt Sustainable Innovation Businesswire
09-Feb-2024 Aptar Reports Fourth Quarter and Annual 2023 Results Businesswire
09-Feb-2024 AdaptHealth Corp. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call Businesswire
09-Feb-2024 Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024 Businesswire
09-Feb-2024 Celyad Oncology Announces Intention to Terminate SEC Reporting Obligations Businesswire
08-Feb-2024 Intellipharmaceutics International Inc. Announces Stock Option Grant AccessWire
08-Feb-2024 Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results AccessWire
08-Feb-2024 Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results AccessWire
08-Feb-2024 Viz.ai Receives FDA 510(k) Clearance for Artificial Intelligence Algorithm for the Quantification of Intracerebral Hemorrhage Businesswire
08-Feb-2024 TRYP THERAPEUTICS OBTAINS INTERIM ORDER FOR PLAN OF ARRANGEMENT AND PROVIDES DETAILS OF SHAREHOLDER MEETING Tryp Therapeutics Inc.
08-Feb-2024 Tryp Therapeutics Obtains Interim Order for Plan of Arrangement and Provides Details of Shareholder Meeting AccessWire
08-Feb-2024 MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital Businesswire
08-Feb-2024 Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of January 31st, 2024 Businesswire
08-Feb-2024 X-FAB Fourth Quarter and Full Year 2023 Results Businesswire